---
title: "DXCM SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for DexCom (DXCM), with links to the SEC filings."
url: "https://tradytics.com/research/DXCM/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=DXCM&v=stock-11994860"
---

# DXCM financial statements and SEC filings

## DXCM annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $4.66B | $911.80M | $836.30M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm) |
| 2024-12-31 | $4.03B | $600.00M | $576.20M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm) |
| 2023-12-31 | $3.62B | $597.70M | $541.50M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm) |
| 2022-12-31 | $2.91B | $391.20M | $341.20M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355725000036/0001093557-25-000036-index.htm) |
| 2021-12-31 | $2.45B | $265.80M | $216.90M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355724000021/0001093557-24-000021-index.htm) |
| 2020-12-31 | $1.93B | $299.50M | $549.70M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355723000024/0001093557-23-000024-index.htm) |

## DXCM annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $6.34B | $3.59B | $2.75B | [10-Q](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000195/0001093557-26-000195-index.htm) |
| 2024-12-31 | $6.48B | $4.38B | $2.10B | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm) |
| 2023-12-31 | $6.26B | $4.20B | $2.07B | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355725000036/0001093557-25-000036-index.htm) |
| 2022-12-31 | $5.39B | $3.26B | $2.13B | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355724000021/0001093557-24-000021-index.htm) |
| 2021-12-31 | $4.93B | $2.89B | $2.04B | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355723000024/0001093557-23-000024-index.htm) |
| 2020-12-31 | $4.29B | $2.46B | $1.83B | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355722000014/0001093557-22-000014-index.htm) |

## DXCM annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $1.44B | -$363.50M | -$1.69B | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm) |
| 2024-12-31 | $989.50M | -$358.80M | -$734.80M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm) |
| 2023-12-31 | $748.50M | -$236.60M | -$318.60M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm) |
| 2022-12-31 | $669.50M | -$364.80M | -$552.50M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355725000036/0001093557-25-000036-index.htm) |
| 2021-12-31 | $442.50M | -$389.20M | $10.40M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355724000021/0001093557-24-000021-index.htm) |
| 2020-12-31 | $475.60M | -$199.00M | $912.10M | [10-K](https://www.sec.gov/Archives/edgar/data/1093557/000109355723000024/0001093557-23-000024-index.htm) |

- [DXCM stock research](https://tradytics.com/research/DXCM)
- [DXCM financial summary](https://tradytics.com/research/DXCM/financials)
- [Read the data without JavaScript](https://tradytics.com/research/DXCM/fundamentals?snapshot=1)
